Clinical Trial Update: Comparing Post-intravitreal Injection Pain Scores Using Loteprednol, Bromfenac Sodium, and Artificial Tears Over a 24-hour Period [Phase 4]

View source ↗

Summary

Phase 4 trial comparing post-intravitreal injection pain scores when using loteprednol etabonate, bromfenac sodium, or artificial tears in patients with retinal…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-related Macular Degeneration
• Diabetic Retinopathy
• Macular Edema
• Retinal Vein Occlusion

Drugs mentioned

• Artificial Tears
• BROMFENAC (Bromfenac)
• Lotemax (Loteprednol etabonate)

Snippet

Sponsor: Retina Research Institute, LLC | Conditions: Vein Occlusion, Macular Degeneration Choroidal Neovascularization | Phase 4 | Status: COMPLETED